Skip to main content
Advertisement
Advertisement

ASMB

ASMB logo

Assembly Biosciences, Inc

23.48
USD
Sponsored
-0.13
-0.55%
Sep 29, 16:00 UTC -4
Closed
exchange

After-Market

23.49

+0.01
+0.04%

ASMB Earnings Reports

Positive Surprise Ratio

ASMB beat 28 of 40 last estimates.

70%

Next Report

Date of Next Report
Nov 09, 2026
Estimate for Q3 26 (Revenue/ EPS)
$7.61M
/
-$0.51
Implied change from Q2 26 (Revenue/ EPS)
-43.11%
/
+155.00%
Implied change from Q3 25 (Revenue/ EPS)
-29.48%
/
-29.17%

Assembly Biosciences, Inc earnings per share and revenue

On Aug 13, 2026, ASMB reported earnings of -0.20 USD per share (EPS) for Q2 26, beating the estimate of -0.65 USD, resulting in a 69.68% surprise. Revenue reached 13.37 million, compared to an expected 8.77 million, with a 52.48% difference. The market reacted with a +10.02% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 4 analysts forecast an EPS of -0.51 USD, with revenue projected to reach 7.61 million USD, implying an increase of 155.00% EPS, and decrease of -43.11% in Revenue from the last quarter.
FAQ
For Q2 2026, Assembly Biosciences, Inc reported EPS of -$0.20, beating estimates by 69.68%, and revenue of $13.37M, 52.48% above expectations.
The stock price moved up 10.02%, changed from $29.95 before the earnings release to $32.95 the day after.
The next earning report is scheduled for Nov 09, 2026.
Based on 4 analysts, Assembly Biosciences, Inc is expected to report EPS of -$0.51 and revenue of $7.61M for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement